Skip to main content

Advertisement

Table 3 OS and DFS for the whole group

From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Group Adjuvant chemotherapy Group (n = 150)   Adjuvant chemo-radiotherapy Group (n = 115) P value
3-year 5-year 3-year 5-year
OS 92.66% 84.37%   95.65% 89.67% 0.341
DFS 84.0% 76.70%   88.53% 85.54% 0.084
  1. Abbreviations: adjuvant-chemo adjuvant chemotherapy, DFS disease-free survival, OS overall survival